Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer.
Journal: JCI insight
Published: May 03, 2018
Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.
Journal: The Journal of clinical investigation
Published: December 07, 2015
EAG2 potassium channel with evolutionarily conserved function as a brain tumor target.
Journal: Nature neuroscience
Published: June 25, 2015
WITHDRAWN: Enhanced Detection and Phenotypic and Karyotypic in Situ Characterization of Circulating Tumor Cells.
Journal: The American journal of pathology
Published: May 05, 2014
Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 06, 2013
Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.
Journal: Blood
Published: December 01, 2012
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics.
Journal: Genes & development
Published: August 03, 2012
Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 10, 2012
Upregulation of Cyclin B1 by miRNA and its implications in cancer.
Journal: Nucleic acids research
Published: November 05, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026